Yahuilong released its 2026 half-year report, with first-half net profit attributable to the parent of 70.13 million yuan, up 166.97% year-on-year. The company's operating revenue was 888 million yuan, up 9.8% year-on-year; net profit attributable to the parent after deducting non-recurring items was 73.46 million yuan, up 46.8% year-on-year; net operating cash flow was 203 million yuan; earnings per share were 0.12 yuan. In the second quarter, the company's operating revenue was 490 million yuan, up 25.5% year-on-year; net profit attributable to the parent was 52.18 million yuan, up 223.7% year-on-year. As of the end of the second quarter, the company's total assets were 4.36 billion yuan, up 1.7% from the end of the previous year; net assets attributable to the parent were 2.752 billion yuan, up 2.02% from the end of the previous year. The company stated that no major risks occurred during the reporting period, business operations were stable, domestic market demand recovered, and international market demand continued to grow.
Shenzhen YHLO Biotech Co. Ltd. AFirst-half net profit attributable to parent surged 166.97% year-on-year, with strong Q2 growth.